BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11752874)

  • 1. A short assessment of sublingual immunotherapy.
    Rakoski J; Wessner D
    Int Arch Allergy Immunol; 2001 Nov; 126(3):185-7. PubMed ID: 11752874
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy.
    Wilkinson J
    Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of sublingual immunotherapy in children.
    Bufe A
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
    Wolthers OD; Høst A; Frederiksen B; Halken S
    Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment.
    Durham SR
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():121-7; discussion 127-31. PubMed ID: 20799452
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: a pilot study.
    Allam JP; Wuestenberg E; Wolf H; Klimek L; Decot E; Horn A; Schnitker J; Bieber T; Novak N
    J Allergy Clin Immunol; 2014 Jun; 133(6):1757-9.e3. PubMed ID: 24794686
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ragweed sublingual tablet immunotherapy: part I - evidence-based clinical efficacy and safety.
    Creticos PS; Pfaar O
    Immunotherapy; 2018 Jun; 10(7):605-616. PubMed ID: 29634392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever.
    Kay AB
    Drugs Today (Barc); 2007 Dec; 43(12):841-8. PubMed ID: 18174969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis caused by in-season switchover of sublingual immunotherapy formulation.
    Hsiao KC; Smart J
    Pediatr Allergy Immunol; 2014 Nov; 25(7):714-5. PubMed ID: 25200920
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Evidence for a dose-response relationship.
    André C; Perrin-Fayolle M; Grosclaude M; Couturier P; Basset D; Cornillon J; Piperno D; Girodet B; Sanchez R; Vallon C; Bellier P; Nasr M
    Int Arch Allergy Immunol; 2003 Jun; 131(2):111-8. PubMed ID: 12811019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy.
    Frew AJ
    N Engl J Med; 2008 May; 358(21):2259-64. PubMed ID: 18499568
    [No Abstract]   [Full Text] [Related]  

  • 15. Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy?
    Nakonechna A; Hills J; Moor J; Dore P; Abuzakouk M
    Ann Allergy Asthma Immunol; 2015 Jan; 114(1):73-4. PubMed ID: 25457868
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological mechanisms in sublingual immunotherapy.
    Bohle B
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():95-6. PubMed ID: 19221631
    [No Abstract]   [Full Text] [Related]  

  • 17. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy: focus on tablets.
    Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):4-9. PubMed ID: 26123419
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of AIT in children including potential to prevent the development of asthma.
    Valovirta E
    Allergy; 2011 Jul; 66 Suppl 95():53-4. PubMed ID: 21668856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.